Martin R. Farlow
0000-0001-7897-5471
Publication & Citation Trends
Publications
700 total
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease PDF
Cited by 1,803
OpenAlex
Long-term safety and efficacy of 13.3 mg/24 h rivastigmine patch in severe Alzheimer's disease: ACTivities of daily living and cognitION (ACTION) study
Cited by 2
Semantic Scholar
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease PDF
Cited by 2,004
OpenAlex
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. OA
Cited by 92
Semantic Scholar
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. OA
Cited by 52
Semantic Scholar
Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials
Cited by 36
Semantic Scholar
Treatment of mild cognitive impairment (MCI).
Cited by 67
Semantic Scholar
Research Topics
Alzheimer's disease research and treatments
(346)
Dementia and Cognitive Impairment Research
(307)
Cholinesterase and Neurodegenerative Diseases
(108)
Functional Brain Connectivity Studies
(94)
Prion Diseases and Protein Misfolding
(50)
Affiliations
Rutgers, The State University of New Jersey
Boston University
University of Southern California
University of North Texas
University of Iowa